A Chart Review on the Feasibility and Safety of the Vincristine Irinotecan Pazopanib (VIPaz) Association in Children and Adolescents With Resistant or Relapsed Sarcomas

Background: Pediatric patients with relapsed or refractory sarcomas have poor outcome and need novel therapies that provide disease control while maintaining an acceptable quality of life. The safety of vincristine, irinotecan, and pazopanib (VIPaz) association has not yet been published in this pop...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: Russo, Ida, Di Paolo, Virginia, Crocoli, Alessandro, Mastronuzzi, Angela, Serra, Annalisa, Di Paolo, Pier Luigi, Di Giannatale, Angela, Miele, Evelina, Milano, Giuseppe Maria
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425124/
https://ncbi.nlm.nih.gov/pubmed/32850366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01228
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares